Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › INDV

DEERFIELD MANAGEMENT COMPANY, L.P. position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 1,648,895 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$67.7M, representing 0.85% of its reported portfolio and ranking #33 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.65M sh
Reported value held$67.65M
Portfolio Weight0.85%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s INDV position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in INDV in Q3 2024 at 5,092,642 shares (US$49.7M). The position peaked in Q3 2025 at 6,986,811 shares, worth US$168.5M. Across 8 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,648,895 shares valued at US$67.7M — a reduction of -1,448,895 shares quarter over quarter.. Notable position changes include a 74% increase in Q4 2024 (shares fell 23% over the following quarter), a 51% trim in Q4 2025 (shares fell 15% over the following quarter), a 47% trim in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 5.09M $49.65M New
Q4 2024 8.88M $110.42M Add
Q1 2025 10.57M $100.71M Add
Q2 2025 10.57M $155.76M Hold
Q3 2025 6.99M $168.45M Reduce
Q4 2025 3.39M $121.74M Reduce
Q1 2026 3.10M $94.42M Reduce
Q2 2026 1.65M $67.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held INDV?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in INDV?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 1.65M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $67.65M, representing 0.85% of its reported portfolio and ranking #33.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling INDV?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. reduced its position in INDV. The position peaked in Q3 2025 at 6.99M shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.